Database and AI Diagnostic Tools Improve Understanding of Lung Damage, Correlation of Pulmonary Disease and Brain Damage in COVID-19
- PMID: 36016071
- PMCID: PMC9414394
- DOI: 10.3390/s22166312
Database and AI Diagnostic Tools Improve Understanding of Lung Damage, Correlation of Pulmonary Disease and Brain Damage in COVID-19
Abstract
The COVID-19 pandemic caused a sharp increase in the interest in artificial intelligence (AI) as a tool supporting the work of doctors in difficult conditions and providing early detection of the implications of the disease. Recent studies have shown that AI has been successfully applied in the healthcare sector. The objective of this paper is to perform a systematic review to summarize the electroencephalogram (EEG) findings in patients with coronavirus disease (COVID-19) and databases and tools used in artificial intelligence algorithms, supporting the diagnosis and correlation between lung disease and brain damage, and lung damage. Available search tools containing scientific publications, such as PubMed and Google Scholar, were comprehensively evaluated and searched with open databases and tools used in AI algorithms. This work aimed to collect papers from the period of January 2019-May 2022 including in their resources the database from which data necessary for further development of algorithms supporting the diagnosis of the respiratory system can be downloaded and the correlation between lung disease and brain damage can be evaluated. The 10 articles which show the most interesting AI algorithms, trained by using open databases and associated with lung diseases, were included for review with 12 articles related to EEGs, which have/or may be related with lung diseases.
Keywords: AI diagnostic; EEG; SARS-CoV-2; artificial intelligence; brain damage; databases; lung diseases; pulmonary disease.
Conflict of interest statement
None of the authors have any potential conflict of interest.
Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Measures implemented in the school setting to contain the COVID-19 pandemic.Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 May 2;5:CD015029. doi: 10.1002/14651858.CD015029.pub2. PMID: 35037252 Free PMC article. Updated.
-
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240. Health Technol Assess. 2006. PMID: 16796930
Cited by
-
An Intelligent Sensor Based Decision Support System for Diagnosing Pulmonary Ailment through Standardized Chest X-ray Scans.Sensors (Basel). 2022 Oct 2;22(19):7474. doi: 10.3390/s22197474. Sensors (Basel). 2022. PMID: 36236573 Free PMC article.
-
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.Front Microbiol. 2023 Nov 23;14:1320856. doi: 10.3389/fmicb.2023.1320856. eCollection 2023. Front Microbiol. 2023. PMID: 38075874 Free PMC article.
-
A Patient-Centered Perspectives and Future Directions in AI-powered Teledentistry.Discoveries (Craiova). 2024 Dec 31;12(4):e199. doi: 10.15190/d.2024.18. eCollection 2024 Oct-Dec. Discoveries (Craiova). 2024. PMID: 40109877 Free PMC article. Review.
References
-
- Galanopoulou A.S., Ferastraoaru V., Correa D.J., Cherian K., Duberstein S., Gursky J., Hanumanthu R., Hung C., Molinero I., Khodakivska O., et al. EEG Findings in Acutely Ill Patients Investigated for SARS-CoV-2/COVID-19: A Small Case Series Preliminary Report. Epilepsia Open. 2020;5:314–324. doi: 10.1002/epi4.12399. - DOI - PMC - PubMed
-
- Corazza L.A., Tatsch J.F.S., Barros M.P., de Queiroz A.P., Batista L.L.R., Aidar M.B., Baldocchi M.A., Rocha M.S.G., Brucki S.M.D. Electroencephalographic Findings among Inpatients with COVID-19 in a Tertiary Hospital from a Middle-Income Country. Arq. Neuro-Psiquiatr. 2021;79:315–320. doi: 10.1590/0004-282x-anp-2020-0555. - DOI - PMC - PubMed
-
- Mahammedi A., Ramos A., Bargalló N., Gaskill M., Kapur S., Saba L., Carrete H., Sengupta S., Salvador E., Hilario A., et al. Brain and Lung Imaging Correlation in Patients with COVID-19: Could the Severity of Lung Disease Reflect the Prevalence of Acute Abnormalities on Neuroimaging? A Global Multicenter Observational Study. AJNR Am. J. Neuroradiol. 2021;42:1008–1016. doi: 10.3174/ajnr.A7072. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous